The MarketWatch News Department was not involved in the creation of this content.-- Phase 1 data for DMX-1001 (noribogaine) support advancement into Phase 2 clinical trial in AUD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback